Abstract
Methods As a clinical pharmacologist with some training in neurology, I have been running an epilepsy clinic for many years. This review is based on a synthesis of my personal experience, information from published studies, and opinions imparted by other epilepsy specialists in publications and at recent conferences. I have selected references to support important points and to provide access to additional information, including opinion that differs (in shade at least) from my own. Acknowledgments Competing interests: During the past five years MF has attended epilepsy meetings abroad as a guest of the manufacturers of all four of the “new” drugs currently marketed in the United Kingdom.